Potential role for interleukin-10 in the immunosuppression associated with kala azar.
Authors:
- M M PompeuMPM M Pompeu
- S JeronimoS Jeronimo
- M J TexeiraMTM J Texeira
- A de A SousaASA de A Sousa
- A W VasconcelosAVA W Vasconcelos
- R D PearsonRPR D Pearson
- J S AbramsJAJ S Abrams
- R M LocksleyRLR M Locksley
- 1 December 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (6) , 2626-2632
Abstract
Patients with acute kala azar are generally nonreactive in a number of immunologic assays, including T cell proliferation and generation of macrophage-activating cytokines, principally IFN-gamma, in response to leishmania antigens in vitro. To test for potential immunosuppressive factors, a series of T cell lines and clones were established from patients with acute kala azar, from patients after chemotherapy for kala azar, and from skin test-positive adults from the same endemic region. Although CD4+ T cell lines and clones could be readily established from the skin test-positive adults, lines and clones from acute or treated patients were heavily biased in expression of CD8+. The CD8+ cells from acute patients did not themselves release cytokines in response to leishmania antigens in vitro, but markedly affected the cytokine profile of peripheral blood mononuclear cells isolated 1 yr later after recovery. Addition of the CD8+ cells caused inhibition of lymphoproliferation and IFN-gamma release, with augmentation of IL-6 and IL-10 release. The inhibitory effects of the CD8+ cells could be partially abrogated by antibodies to IL-10 but not by antibodies to IL-4. Analysis of four patients with acute kala azar demonstrated release of IL-10 that could not be demonstrated in supernatants from asymptomatic skin test-positive individuals. Generation of IL-10 may contribute to the profound suppression of IFN-gamma release that occurs during kala azar due to Leishmania chagasi.Keywords
This publication has 26 references indexed in Scilit:
- In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.Journal of Clinical Investigation, 1993
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.The Journal of Immunology, 1989
- Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.The Journal of Immunology, 1989
- Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.Journal of Clinical Investigation, 1989
- Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4Journal of Immunological Methods, 1989
- Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.Journal of Experimental Medicine, 1988
- An analysis of T cell responsiveness in Indian kala-azar.The Journal of Immunology, 1987
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.Journal of Clinical Investigation, 1985
- An Easily Prepared Defined Medium for Cultivation of Leishmania donovani PromastigotesJournal of Parasitology, 1978